CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($) shares in Millions, $ in Millions	Total	Shareholders' Equity [Member]	Common Stock [Member]	Add'l Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accum. Other Comp. Loss [Member]		Noncontrolling Interests [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			9,471
Beginning balance at Dec. 31, 2021	$ 77,462	$ 77,201	$ 473	$ 90,591	$ (111,361)	$ 103,394	$ (5,897)		$ 262
Beginning balance (in shares) at Dec. 31, 2021					(3,851)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17,781	17,769				17,769			12
Other comprehensive income/(loss), net of tax	(1,228)	(1,223)					(1,223)		(6)
Cash dividends declared, per share
Common stock	(4,489)	(4,489)				(4,489)
Share-based payment transactions (in shares)			25		(12)
Share-based payment transactions	(53)	(53)	$ 2	588	$ (578)	(66)
Purchases of common stock (in shares)					(39)
Purchases of common stock	(2,000)	(2,000)			$ (2,000)
Other	(4)	3		3					(7)
Ending balance (in shares) at Jul. 03, 2022			9,496
Ending balance at Jul. 03, 2022	87,469	87,208	$ 476	91,183	$ (113,939)	116,608	(7,119)		261
Ending balance (in shares) at Jul. 03, 2022					(3,903)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			9,494
Beginning balance at Apr. 03, 2022	82,685	82,424	$ 476	90,844	$ (113,931)	111,193	(6,157)		261
Beginning balance (in shares) at Apr. 03, 2022					(3,903)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,911	9,906				9,906			6
Other comprehensive income/(loss), net of tax	(968)	(963)					(963)		(5)
Cash dividends declared, per share
Common stock	(4,489)	(4,489)				(4,489)
Share-based payment transactions (in shares)			2
Share-based payment transactions	330	330		339	$ (8)	(2)
Other	0
Ending balance (in shares) at Jul. 03, 2022			9,496
Ending balance at Jul. 03, 2022	87,469	87,208	$ 476	91,183	$ (113,939)	116,608	(7,119)		261
Ending balance (in shares) at Jul. 03, 2022					(3,903)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			9,496
Beginning balance (in shares)			9,519
Beginning balance at Dec. 31, 2022	95,916	95,661	$ 476	91,802	$ (113,969)	125,656	(8,304)		256
Beginning balance (in shares) at Dec. 31, 2022					(3,903)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,894	7,870				7,870			24
Other comprehensive income/(loss), net of tax	196	202					202	[1]	(6)
Cash dividends declared, per share
Common stock	(4,630)	(4,630)				(4,630)
Share-based payment transactions (in shares)			42		(12)
Share-based payment transactions	(85)	(85)	$ 2	527	$ (512)	(101)
Other	0
Ending balance (in shares) at Jul. 02, 2023			9,561
Ending balance at Jul. 02, 2023	99,293	99,019	$ 478	92,329	$ (114,482)	128,796	(8,102)		274
Ending balance (in shares) at Jul. 02, 2023					(3,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			9,560
Beginning balance at Apr. 02, 2023	101,236	100,970	$ 478	92,153	$ (114,473)	131,101	(8,289)		266
Beginning balance (in shares) at Apr. 02, 2023					(3,915)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,338	2,327				2,327			11
Other comprehensive income/(loss), net of tax	184	187					187		(3)
Cash dividends declared, per share
Common stock	(4,630)	(4,630)				(4,630)
Share-based payment transactions (in shares)			1
Share-based payment transactions	164	164		176	$ (8)	(4)
Other	0
Ending balance (in shares) at Jul. 02, 2023			9,561
Ending balance at Jul. 02, 2023	$ 99,293	$ 99,019	$ 478	$ 92,329	$ (114,482)	$ 128,796	$ (8,102)		$ 274
Ending balance (in shares) at Jul. 02, 2023					(3,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			9,561

[1] Foreign currency translation adjustments include net gains related to our equity-method investment in Haleon (see Note 2C) and the impact of our net investment hedging program.